Visual Outcome in Children With Congenital Glaucoma.
10.3341/jkos.2009.50.5.743
- Author:
Min Wook CHANG
1
;
Yong Yeon KIM
;
Seung Hyun KIM
Author Information
1. Department of Ophthalmology, Korea University College of Medicine, Seoul, Korea. ansaneye@hanmail.net
- Publication Type:Original Article
- Keywords:
Amblyopia;
CD ratio;
IOP;
Primary congenital glaucoma;
Visual acuity
- MeSH:
Amblyopia;
Child;
Eye;
Glaucoma;
Humans;
Prevalence;
Prognosis;
Refractive Errors;
Vision, Ocular;
Visual Acuity
- From:Journal of the Korean Ophthalmological Society
2009;50(5):743-748
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE:To evaluate the prognosis of vision and the development of amblyopia in primary congenital glaucoma patients. METHODS: The author reviewed 38 eyes of 22 primary congenital glaucoma patients and evaluated variables such as age at time of surgery and at the last visit, preoperative IOP, Cup-to-disc(CD) ratio, corneal diameter, refractive error, axial lengths and IOP, CD ratio and visual acuity at the last visit. According to visual acuity, the patients were divided into 3 groups, good (>0.5), fair (0.1~0.5), and poor (<0.1). The amblyopia was defined when BCVA was below 0.8 and no evidence of progression of glaucoma. There were 4 types of amblyopia: deprivation, anisometropic, strabismic and organic. The author compared the 3 groups and evaluated factors affecting the vision as well as the prevalence of amblyopia. RESULTS: There were 17 eyes in the good group, 4 eyes in the fair group and 17 eyes in the poor group (p<0.05). Amblyopia developed in 17 eyes with 7 eyes showing deprivation amblyopia. Anisometropic and organic amblyopia were each found in 4 eyes, and strabismic amblyopia was found in 2 eyes. The postoperative IOP and CD ratio and preoperative CD ratio were significantly lower in the good group than the other groups (p<0.05). CONCLUSIONS: Final VA was poor in 45% of eyes with primary congenital glaucoma, and amblyopia developed in 45% of these eyes. The prognosis for vision may be related to the treatment of glaucoma and amblyopia.
